Clever Leaves Holdings Inc. (CLVR) vs Sofgen Pharma S.A (PROCF)
- Clever Leaves Holdings Inc. CLVR 0.01 0.00%
- Sofgen Pharma S.A PROCF 0.03 0.00%
Clever Leaves Holdings Inc. and Sofgen Pharma S.A are both Drug Manufacturers Specialty & Generic companies. Sofgen Pharma S.A is the larger, with a market value of $114.0M against $96.5M — 1.2× the size. Clever Leaves Holdings Inc. has negative trailing earnings, so its P/E is not meaningful; Sofgen Pharma S.A trades at 0.1×. Clever Leaves Holdings Inc. grew revenue faster over the last twelve months: 6.14% against 5.10%. Sofgen Pharma S.A has the higher net margin (9.52% vs −102.8%) and the higher return on invested capital (15.2% vs −52.6%). Across the 17 metrics below, Sofgen Pharma S.A leads on 10 and Clever Leaves Holdings Inc. on 7.
Valuation
| Metric | CLVR | PROCF | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| P/E | n/m | 0.07 | 19.25 |
| P/S | 0.00 | 0.01 | 2.11 |
| P/B | 0.00 | n/m | 1.78 |
| Price to free cash flow | n/m | 0.04 | 16.14 |
| EV/EBITDA | 0.44 | 3.32 | 12.58 |
| EV/Sales | (0.33) | 0.71 | 2.73 |
| Earnings yield | (113,051.00%) | 1,354.00% | (4.38%) |
| Free cash flow yield | (55,338.01%) | 2,469.89% | 0.00% |
Profitability
| Metric | CLVR | PROCF | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 37.64% | 56.16% | 53.94% |
| Operating margin | (89.53%) | 17.01% | 0.00% |
| Net margin | (102.77%) | 9.52% | 0.00% |
| Free cash flow margin | (49.82%) | 17.66% | 0.00% |
| Return on equity | (55.39%) | (213.06%) | (0.40%) |
| Return on assets | (42.95%) | 8.82% | (3.32%) |
| Return on invested capital | (52.59%) | 15.21% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack